Alterity Therapeutics Limited
PRNAF
Price:
$0.055
Market Cap:
$125.07M
Alterity Therapeutics Limited, an Australian-based company, is dedicated to the discovery and development of pharmaceutical treatments for a range of neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases. The firm's leading experimental medication, ATH434, has successfully concluded its Phase I clinical trials for Parkinson's disease. Furthermore, Alterity is advancing PBT2, a compound that has already completed Phase IIa clinical trials targeting Alzheimer's disease. Formed in 1997 and headquartered in Melbourne, Australia, the company rebranded from Prana Biotechnology Limited to Alterity Therapeutics Limited in April 2019.
Industry
Biotechnology
IPO Date
2012-09-25
Stock Exchange
OTC
Ticker
PRNAF
PE Ratio
[-1.10]
ROE
[-30.19%]
Current Ratio
[21.98]
Dividend Yield
[0%]
Enterprise Value
[76.03M]
Dividend History
The ROE as of June 2026 (TTM) for Alterity Therapeutics Limited (PRNAF) is -30.19%
According to Alterity Therapeutics Limited’s latest financial reports and current stock price. The company's current ROE is -30.19%. This represents a change of -43.32% compared to the average of -53.25% of the last 4 quarters.
Alterity Therapeutics Limited (PRNAF) Historical ROE (quarterly & annually)
How has PRNAF ROE performed in the past?
The mean historical ROE of Alterity Therapeutics Limited over the last ten years is -58.97%. The current -30.19% ROE has changed -48.82% with respect to the historical average. Over the past ten years (40 quarters), PRNAF's ROE was at its highest in in the December 2014 quarter at -3.43%. The ROE was at its lowest in in the December 2010 quarter at -126.15%.
Average
-58.97%
Median
-50.82%
Minimum
-138.60%
Maximum
-24.64%
Alterity Therapeutics Limited (PRNAF) ROE by Quarter and Year
Discovering the peaks and valleys of Alterity Therapeutics Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 129.01%
Maximum Annual ROE = -24.64%
Minimum Annual Increase = -79.33%
Minimum Annual ROE = -138.60%
| Year | ROE | Change |
|---|---|---|
| 2025 | -28.65% | -79.33% |
| 2024 | -138.60% | 129.01% |
| 2023 | -60.52% | 67.09% |
| 2022 | -36.22% | -27.91% |
| 2021 | -50.24% | -47.32% |
| 2020 | -95.37% | 31.99% |
| 2019 | -72.26% | 40.58% |
| 2018 | -51.40% | 61.45% |
| 2017 | -31.84% | 29.20% |
| 2016 | -24.64% | 63.78% |
Alterity Therapeutics Limited (PRNAF) Average ROE
How has PRNAF ROE performed in the past?
The current ROE of Alterity Therapeutics Limited (PRNAF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-75.92%
5-year avg
-62.85%
10-year avg
-58.97%
Alterity Therapeutics Limited (PRNAF) ROE vs. Peers
How is PRNAF’s ROE compared to its peers?
Alterity Therapeutics Limited’s ROE is greater than BioStem Technologies, Inc. (-47.03%), greater than Nicox S.A. (-51.16%), greater than IXICO plc (-16.18%), greater than Calliditas Therapeutics Ab (-84.68%), greater than Imugene Limited (-134.65%), greater than Actinogen Medical Limited (-134.14%), greater than Starpharma Holdings Limited (-15.96%), greater than Helix BioPharma Corp. (-21.54%), greater than PsyBio Therapeutics Corp. (-867.29%), greater than Satellos Bioscience Inc. (-51.42%),
| Company | ROE | Market cap |
|---|---|---|
| -47.03% | $70.55M | |
| -51.16% | $30.94M | |
| -16.18% | $6.51M | |
| -84.68% | $19.80M | |
| -134.65% | $35.35M | |
| -134.14% | $2.87M | |
| -15.96% | $193.63M | |
| -21.54% | $130.61M | |
| -867.29% | $1.27K | |
| -51.42% | $96.62M |
Build a custom stock screener for Alterity Therapeutics Limited (PRNAF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alterity Therapeutics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Alterity Therapeutics Limited (PRNAF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Alterity Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Alterity Therapeutics Limited's ROE?
How is the ROE calculated for Alterity Therapeutics Limited (PRNAF)?
What is the highest ROE for Alterity Therapeutics Limited (PRNAF)?
What is the 3-year average ROE for Alterity Therapeutics Limited (PRNAF)?
What is the 5-year average ROE for Alterity Therapeutics Limited (PRNAF)?
How does the current ROE for Alterity Therapeutics Limited (PRNAF) compare to its historical average?